Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?

Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?

Diana L Castillo-Carranza,1,2 Marcos J Guerrero-Muñoz,1,2 Rakez Kayed1–31Mitchell Center for Neurodegenerative Diseases, 2Departments of Neurology, Neuroscience, and Cell Biology, 3Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX, USAAbstra...

Full description

Bibliographic Details
Main Authors: Castillo-Carranza DL, Guerrero-Muñoz MJ, Kayed R
Format: Article
Language:English
Published: Dove Medical Press 2013-12-01
Series:ImmunoTargets and Therapy
Subjects:
Immunotherapy
Alzheimer’s disease
β-amyloid
tau
Online Access:https://www.dovepress.com/immunotherapy-for-the-treatment-of-alzheimer39s-disease-amyloid-beta-o-peer-reviewed-article-ITT

Internet

https://www.dovepress.com/immunotherapy-for-the-treatment-of-alzheimer39s-disease-amyloid-beta-o-peer-reviewed-article-ITT

Similar Items